Lee's Pharmaceutical Holdings financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
HK$30.40M HK$38.53M HK$43.53M HK$76.71M HK$125.42M HK$173.84M HK$255.81M HK$399.69M HK$534.33M HK$696.95M HK$955.21M HK$922.15M HK$929.82M HK$1.01B HK$1.14B HK$1.22B HK$1.22B HK$1.27B HK$1.23B HK$0.00M HK$0.00M
GM % Gross Margin %
65.85% 65.70% 61.27% 66.47% 70.68% 71.66% 69.77% 73.02% 71.27% 72.21% 70.20% 70.29% 71.87% 67.66% 65.61% 65.49% 64.19% 63.68% 62.50% 0.00% 0.00%
OM Operating Margin
-9.70% 1.22% -6.45% 17.53% 24.60% 30.71% 27.28% 23.01% 24.73% 25.40% 24.74% 26.88% 31.76% 23.67% 16.25% 15.66% 5.62% -7.51% 10.33% 0.00% 0.00%
EPS Earnings Per Share
HK$0.12 HK$0.18 HK$0.22 HK$0.27 HK$0.34 HK$0.39 HK$0.43 HK$0.39 HK$0.34 HK$0.21 HK$0.22 HK$3.38 HK$0.09 HK$0.13 HK$0.00
Div. Dividends
HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.03 HK$0.04 HK$0.06 HK$0.08 HK$0.09 HK$0.10 HK$0.11 HK$0.10 HK$0.12 HK$0.06 HK$0.06 HK$0.06 HK$0.02 HK$0.00 HK$0.00
PR % Payout Ratio %
0 0 0 0 0 0 25.00% 22.22% 27.27% 29.63% 26.47% 25.64% 25.58% 25.64% 35.29% 28.57% 27.27% 1.78% 22.22% 0.00% 0
Sha. Shares
289.23m 346.23m 346.23m 413.13m 415.28m 450.11m 465.83m 469.73m 521.1m 538.25m 544.72m 586.8m 589.92m 590.94m 592.03m 587.92m 588.13m 588.84m 588.84m 588.84m 0m
OCF Operating Cash Flow
HK$-5.78M HK$0.11M HK$0.51M HK$9.40M HK$26.20M HK$54.38M HK$68.21M HK$88.01M HK$174.43M HK$179.27M HK$220.31M HK$160.23M HK$394.54M HK$365.68M HK$321.25M HK$399.95M HK$218.91M HK$210.68M HK$283.63M HK$0.00M HK$0.00M
FCF Free Cash Flow
HK$-6.38M HK$-1.13M HK$-3.50M HK$7.38M HK$19.68M HK$44.77M HK$60.86M HK$60.49M HK$83.10M HK$33.40M HK$152.43M HK$142.99M HK$83.00M HK$228.52M HK$191.14M HK$281.74M HK$80.51M HK$159.98M HK$266.17M HK$0.00M HK$0.00M
FCFS Free Cash Flow Per Share
HK$-0.02 HK$-0.00 HK$-0.01 HK$0.02 HK$0.05 HK$0.10 HK$0.10 HK$0.10 HK$0.13 HK$-0.01 HK$0.17 HK$-0.13 HK$0.21 HK$0.17 HK$0.05 HK$0.07 HK$-0.24 HK$-0.27 HK$0.12 HK$0.00 HK$0.00